Upgrade to SI Premium - Free Trial

UPDATE: Cowen Upgrades Endocyte (ECYT) to Outperform Citing 'Very Favorable' Risk/Reward at Current Valuation

February 27, 2018 5:33 AM
(Updated - February 27, 2018 7:36 AM EST)

(updated to add analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Upgrades Upgrades

Next Articles